As such, the team concluded that “Efficacy of rivaroxaban vs. warfarin was similar in patients with and without SVD; however, the observed risk of bleeding was higher with rivaroxaban [or, ‘Xarelto’] in patients with SVD but was the same among those without SVD.”

Due to the fact that Bayer has failed to adequately warn Xarelto users of the risk for bleeding, Xarelto lawsuits are currently being filed in great number. If you or a loved one used Xarelto and suffered a major bleeding event, you may be entitled to significant financial compensation as well.

For a free, no-obligation case consultation, contact our team of Xarelto lawyers at the information provided below. We have the experience, resources, and skills required to win the justice you deserve. Call today and see how we can help.

About this Blog

This blog chronicles legal and scientific news relating to personal injuries caused by defective drugs and medical devices. It is published by injury lawyer Justinian C. Lane, an attorney who takes a personal interest in each of his clients’ cases.